-
U251; MCF-7
not specified
RT-qPCR
circCdr1 was reduced in U251 and MCF-7 cells after nitrogenous heterocyclic compound treatment, reported as part of a panel of tumor-related circRNAs regulated by the compound; no specific downstream mechanism was tested for circCdr1.
0.1155
Computer-aided drug design and inhibitive effect of a novel nitrogenous heterocyclic compound and its mechanism on glioma U251 cells and breast cancer MCF-7 cells.
biological research